NEW
Piqray

Piqray Indications/Uses

Manufacturer:

Novartis

Distributor:

Zuellig
Full Prescribing Info
Indications/Uses
Piqray is indicated in combination with fulvestrant for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with a PIK3CA mutation after disease progression following endocrine therapy as monotherapy (see Pharmacology: Pharmacodynamics under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in